Results 11 to 20 of about 7,712 (183)

In vivo expression of peptidylarginine deiminase in Drosophila melanogaster

open access: yesPLOS ONE, 2020
Peptidylarginine deiminase (PAD) modifies peptidylarginine and converts it to peptidylcitrulline in the presence of elevated calcium. Protein modification can lead to severe changes in protein structure and function, and aberrant PAD activity is linked to human pathologies.
Olena Mahneva   +5 more
doaj   +5 more sources

Peptidylarginine deiminases and extracellular vesicles: prospective drug targets and biomarkers in central nervous system diseases and repair [PDF]

open access: yesNeural Regeneration Research, 2021
Peptidylarginine deiminases are a family of calcium-activated enzymes with multifaceted roles in physiological and pathological processes, including in the central nervous system.
Sigrun Lange
doaj   +2 more sources

Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4. [PDF]

open access: yesSci Rep, 2023
Peptidylarginine deiminase 4 (PAD4) contributes to the production of citrullinated proteins as autoantigens for anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA). PAD4 can also self-deiminate via autocitrullination.
Yoshida K   +6 more
europepmc   +3 more sources

Peptidylarginine Deiminase Inhibition Abolishes the Production of Large Extracellular Vesicles From Giardia intestinalis, Affecting Host-Pathogen Interactions by Hindering Adhesion to Host Cells [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Giardia intestinalis is a microaerophilic protozoan that is an important etiologic agent of diarrhea worldwide. There is evidence that under diverse conditions, the parasite is capable of shedding extracellular vesicles (EVs) which modulate the ...
Bruno Gavinho   +9 more
doaj   +2 more sources

Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase [PDF]

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2017
Protein citrullination catalysed by peptidylarginine deiminase (PAD) may play an important pathogenic role in several chronic inflammatory diseases and malignancies. PAD2, PAD4, and citrullinated proteins are found in the synovium of rheumatoid arthritis
Dres Damgaard   +3 more
doaj   +2 more sources

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis [PDF]

open access: yesFrontiers in Immunology, 2018
Increasing evidence suggests that neutrophil extracellular traps (NETs) may play a role in promoting atherosclerotic plaque lesions in humans and in murine models.
Yudong Liu   +10 more
doaj   +2 more sources

Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis

open access: yesArthritis Research & Therapy, 2021
Background Mucosal sites are hypothesized to play a role in the development of rheumatoid arthritis (RA). Since serum anti-peptidylarginine deiminase (PAD)4 antibodies, including a subset that cross-react with PAD3 (PAD3/4), are specific for RA and ...
M. Kristen Demoruelle   +8 more
doaj   +2 more sources

Candida albicans-Induced NETosis Is Independent of Peptidylarginine Deiminase 4 [PDF]

open access: yesFrontiers in Immunology, 2018
Neutrophils are the most abundant innate immune cells and the first line of defense against many pathogenic microbes, including the human fungal pathogen Candida albicans.
Eva Guiducci   +5 more
doaj   +2 more sources

Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer. [PDF]

open access: yesOncogenesis
Neratinib is a tyrosine kinase inhibitor that is used for the therapy of patients with HER2+ breast tumors. However, despite its clinical benefit, resistance to the drug may arise.
Romero-Pérez I   +4 more
europepmc   +3 more sources

Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery

open access: yesJournal of Inflammation Research, 2019
Anne Vejlstrup,1 Ann Merete Møller,2 Claus Henrik Nielsen,1,3,* Dres Damgaard1,3,*1Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; 2Department of
Vejlstrup A   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy